Practice budgets: lifting the veil of ignorance.

by Forbes, J F
Published 1989

Innovation in general practice

by Forbes, J F
Published 1988

Quality and the use of time in general practice: widening the discussion.

by Howie, J. G., Porter, A. M., Forbes, J. F.
Published 1989

Poverty and teenage pregnancy.

by Williams, S, Forbes, J F, McIlwaine, G M, Rosenberg, K
Published 1987

Perinatal mortality in Scotland: 1970-9.

by Forbes, J F, Boddy, F A, Pickering, R, Wyllie, M M
Published 1982

Why costs of consultations in general practice vary.

by Twaddle, S E, Porter, A M, Howie, J G, Forbes, J F
Published 1990

Early participant-reported symptoms as predictors of adherence to anastrozole in the International Breast Cancer Intervention Studies II

by Sestak, I, Smith, S G, Howell, A, Forbes, J F, Cuzick, J
Published in Ann Oncol (2018)

Relationships between CYP2D6 phenotype, breast cancer and hot flushes in women at high risk of breast cancer receiving prophylactic tamoxifen: results from the IBIS-I trial

by Sestak, I, Kealy, R, Nikoloff, M, Fontecha, M, Forbes, J F, Howell, A, Cuzick, J
Published 2012

A new pathological system for grading DCIS with improved prediction of local recurrence: results from the UKCCCR/ANZ DCIS trial

by Pinder, S E, Duggan, C, Ellis, I O, Cuzick, J, Forbes, J F, Bishop, H, Fentiman, I S, George, W D
Published 2010

Improving decision making about clinical trial participation – a randomised controlled trial of a decision aid for women considering participation in the IBIS-II breast cancer prev...

by Juraskova, I, Butow, P, Bonner, C, Bell, M L, Smith, A B, Seccombe, M, Boyle, F, Reaby, L, Cuzick, J, Forbes, J F
Published 2014

The sequential use of endocrine treatment for advanced breast cancer: where are we?

by Barrios, C., Forbes, J. F., Jonat, W., Conte, P., Gradishar, W., Buzdar, A., Gelmon, K., Gnant, M., Bonneterre, J., Toi, M., Hudis, C., Robertson, J. F. R.
Published in Ann Oncol (2012)

Factors affecting baseline quality of life in two international adjuvant breast cancer trials. International Breast Cancer Study Group (IBCSG).

by Bernhard, J., Hürny, C., Coates, A. S., Peterson, H. F., Castiglione-Gertsch, M., Gelber, R. D., Galligioni, E., Marini, G., Thürlimann, B., Forbes, J. F., Goldhirsch, A., Senn, H. J., Rudenstam, C. M.
Published 1998

Patterns and risk factors for locoregional failures after mastectomy for breast cancer: an International Breast Cancer Study Group report

by Karlsson, P., Cole, B. F., Chua, B. H., Price, K. N., Lindtner, J., Collins, J. P., Kovács, A., Thürlimann, B., Crivellari, D., Castiglione-Gertsch, M., Forbes, J. F., Gelber, R. D., Goldhirsch, A., Gruber, G.
Published 2012

Quality of life and quality-adjusted survival (Q-TWiST) in patients receiving dose-intensive or standard dose chemotherapy for high-risk primary breast cancer

by Bernhard, J, Zahrieh, D, Zhang, J J, Martinelli, G, Basser, R, Hürny, C, Forbes, J F, Aebi, S, Yeo, W, Thürlimann, B, Green, M D, Colleoni, M, Gelber, R D, Castiglione-Gertsch, M, Price, K N, Goldhirsch, A, Coates, A S
Published 2008

Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial

by Rabaglio, M., Sun, Z., Price, K. N., Castiglione-Gertsch, M., Hawle, H., Thürlimann, B., Mouridsen, H., Campone, M., Forbes, J. F., Paridaens, R. J., Colleoni, M., Pienkowski, T., Nogaret, J.-M., Láng, I., Smith, I., Gelber, R. D., Goldhirsch, A., Coates, A. S.
Published 2009

Symptoms of endocrine treatment and outcome in the BIG 1–98 study

by Huober, J., Cole, B.F., Rabaglio, M., Giobbie-Hurder, A., Wu, J., Ejlertsen, B., Bonnefoi, H., Forbes, J.F., Neven, P., Láng, I., Smith, I., Wardley, A., Price, K.N., Goldhirsch, A., Coates, A.S., Colleoni, M., Gelber, R.D., Thürlimann, B.
Published 2013

Quantifying trade-offs: quality of life and quality-adjusted survival in a randomised trial of chemotherapy in postmenopausal patients with lymph node-negative breast cancer

by Bernhard, J, Zahrieh, D, Coates, A S, Gelber, R D, Castiglione-Gertsch, M, Murray, E, Forbes, J F, Perey, L, Collins, J, Snyder, R, Rudenstam, C-M, Crivellari, D, Veronesi, A, Thürlimann, B, Fey, M F, Price, K N, Goldhirsch, A, Hürny, C
Published 2004

Which patients benefit most from adjuvant aromatase inhibitors? Results using a composite measure of prognostic risk in the BIG 1-98 randomized trial

by Viale, G., Regan, M. M., Dell'Orto, P., Mastropasqua, M. G., Maiorano, E., Rasmussen, B. B., MacGrogan, G., Forbes, J. F., Paridaens, R. J., Colleoni, M., Láng, I., Thürlimann, B., Mouridsen, H., Mauriac, L., Gelber, R. D., Price, K. N., Goldhirsch, A., Gusterson, B. A., Coates, A. S.
Published 2011

Meeting abstracts from the Annual Conference on Hereditary Cancers 2016: Szczecin, Poland. 14-15 September 2016

by Cybulski, C., Kluźniak, W., Huzarski, T., Wokołorczyk, D., Kashyap, A., Jakubowska, A., Szwiec, M., Byrski, T., Dębniak, T., Górski, B., Sopik, V., Akbari, M. R., Sun, P., Gronwald, J., Narod, S. A., Lubiński, J., Dębniak, T., Dymerska, D., Kurzawski, G., Lubiński, J., Dymerska, D., Tutlewska, K., Kuswik, M., Rudnicka, H., Scott, R. J., Billings, R., Pławski, A., Lubinski, J., Kurzawski, G., Gromowski, T., Kąklewski, K., Marciniak, W., Durda, K., Lener, M., Sukiennicki, G., Kaczmarek, K., Jaworska-Bieniek, K., Paszkowska-Szczur, K., Waloszczyk, P., Lubiński, J., Dębniak, T., Gronwald, J., Hemminki, K., Försti, A., Huzarski, T., Gronwald, J., Cybulski, C., Oszurek, O., Szwiec, M., Gugała, K., Stawicka, M., Morawiec, Z., Mierzwa, T., Falco, M., Janiszewska, H., Kilar, E., Marczyk, E., Kozak-Klonowska, B., Siołek, M., Surdyka, D., Wiśniowski, R., Posmyk, M., Domagała, P., Byrski, T., Sun, P., Lubiński, J., Narod, S. A., Imyanitov, E. N., Kaczmarek, K., Muszyńska, M., Marciniak, W., Sukiennicki, G., Lener, M., Durda, K., Jaworska-Bieniek, K., Gromowski, T., Prajzendanc, K., Peruga, N., Huzarski, T., Byrski, T., Gronwald, J., Cybulski, C., Dębniak, T., Morawski, A., Jakubowska, A., Lubiński, J., Lener, M. R., Scott, R. J., Kluźniak, W., Gronwald, J., Baszuk, P., Cybulski, C., Wiechowska-Kozłowska, A., Huzarski, T., Kładny, J., Pietrzak, S., Soluch, A., Jakubowska, A., Lubiński, J., Plawski, A., Prajzendanc, K., Jakubowska, A., Lubiński, J., Rashid, U. R., Naeemi, H., Muhammad, N., Lubiński, J., Jakubowska, A., Loya, A., Yusuf, M. A., Savanevich, A., Aszurek, O., Gronwald, J., Lubiński, J., Mathe, A., Wong-Brown, M., Locke, W., Stirzaker, C., Braye, S. G., Forbes, J. F., Clark, S., Avery-Kiejda, K., Scott, R. J., Tomiczek-Szwiec, J., Huzarski, T., Szwiec, M., Gronwald, J., Cybulski, C., Marczyk, E., Jakubowicz, J., Kilar, E., Sibilski, R., Stawicka, M., Morawiec, Z., Mierzwa, T., Falco, M., Janiszewska, H., Kozak-Klonowska, B., Siołek, M., Surdyka, D., Wiśniowski, R., Posmyk, R., Domagała, P., Lubiński, J., Szwiec, M., Tomiczek-Szwiec, J., Huzarski, T., Cybulski, C., Lubiński, J.
Published in Hered Cancer Clin Pract (2017)